Bloom's syndrome (BS) is a rare human genetic disorder characterized by mutations within the BLM gene whose primary eects are excessive chromosome breakaoge and increased rates of sister chromatide interchange in somatic cells. We report the characterization of a murine protein (mBLM), highly related to the product of the human BLM gene. This protein exhibits an ATPdependent DNA-helicase activity that unwinds DNA in a 3' ± 5' direction. Single aminoacid substitutions found in BS cells, abolish both ATPase and helicase activities of this protein, indicating that defects in these BLM functions may be primarily responsible for BS establishment. These results provide the ®rst evidence suggesting that the enzymatic activities of the BLM product are implicated in the upholding of genomic integrity.
Introduction
Bloom's syndrome (BS) (German, 1993) is a rare genetic disorder, whose major clinical manifestations are small size, sun sensitive erythema and immunode®ciency. Homozygocity for mutations at the BS locus constitutes a mutator genotype (Ellis and German, 1996) : somatic cells from patients with BS accumulate an excessive number of mutations at all loci examined and exhibit an elevated frequency of interchanges between somatic homologous chromosomes (Ellis et al., 1995b ). An important clinical consequence of this genomic instability is an enormous predisposition to the generality of human cancers (German, 1992) . Because of the high parental consanguinity rate in non-Ashkenazi families with Bloom syndrome, Ellis et al. (1994) were able to do homozygosity mapping. Tight linkage was found with loci on distal 15q, speci®cally 15q26.1 . The causative human gene for BS (BLM) was subsequently identi®ed (Ellis et al., 1995a) , using somatic crossover point mapping. Loss of BLM function can cause a variety of genomic and biochemical aberrations generating abnormal DNA structures during replication aecting the activity of other DNAbinding proteins or activating repair mechanisms (Korn and Ramkissoon, 1995) . BLM encodes a 1417 amino acid polypeptide (hBLM) with strong homology to the RecQ helicases, a subfamily of DEAH box-containing DNA and RNA helicases. Based on these homologies it was postulated that BLM was a helicase (Ellis et al., 1995a) . This assumption was recently directly con®rmed at the biochemical level, demonstrating that the product of the cloned BLM sequences was a bona ®de ATPdependent DNA helicase (Karow et al., 1997) . Although the contribution of this enzyme to the maintenance of the genome integrity has been suggested (Ellis and German, 1996; Karow et al., 1997) , conclusive evidence supporting this view is still lacking.
We have been studying the ATFa transcription factors which belong to the CREB/ATF family of transcription factors. All three isoforms (ATFa1, 2 and 3) mediate the transcriptional activation by the largest adenovirus E1a protein by recruiting it to the promoter of target genes (Chatton et al., 1993) . In addition, they modulate the activity and DNA-binding speci®city of Jun, Fos or related transcription factors, through formation of heterodimers (Chatton et al., 1994; 1995) . Co-immunoprecipitation experiments revealed that the Jun N-terminal Kinase 2 (JNK2), originally found to be associated with Jun, also binds to ATFa (Bocco et al., 1996) .
To identify additional partners of ATFa, we used the yeast two-hybrid system originally developed by Fields and Song (Fields and Song, 1989) . Using this assay, we screened a mouse cDNA library (AB, FDG, CK and BC, in preparation) and isolated several cDNA fragments encoding such potential ATFa partners. Here we describe one of the proteins identi®ed by this assay, the murine homologue (mBLM) of the product of the human Bloom's syndrome gene (hBLM). An extensive sequence comparison between the members of the RecQ family helicases revealed particular features that are located C-terminal to the helicase domain and restricted to polypeptides of eukaryotic origin. We demonstrate that the mBLM protein also exhibits an ATP-dependent DNA helicase activity that unwinds DNA in a 3' to 5' direction. Although many BS mutations truncate the hBLM protein upstream of the helicase domain, four of them represent single aminoacid substitutions (Ellis et al., 1995a; Foucault et al., 1997) . When introduced at corresponding positions into the highly conserved mBLM protein, these point-mutations each abolish both ATPase and helicase activities of the protein, strongly suggesting that defects in these activities of hBLM are responsible for BS establishment.
Results

Isolation of the mBLM cDNA
The mBLM cDNA was recovered by screening a mouse cDNA library with a partial mouse cDNA Figure 1 Sequence analysis of the murine BLM (mBLM) protein. (a) The partial mouse cDNA (mBLMD) used to retrieve the fulllength mBLM cDNA, spans nucleotides 452 ± 1971 (aminoacids 132 ± 637) of the reconstructed mBLM cDNA and was initially isolated by a two-hybrid screen of a mouse cDNA library, using ATFa1 as a bait (AB, FDG, CK and BC, in preparation). Re-probe (mBLMD), that was initially isolated in a twohybrid screen based on the ability of the corresponding polypeptide to interact with the ATFa transcription factors (AB, FDG, CK and BC, in preparation; Figure  1a) . The complete open reading frame of the mBLM cDNA, reconstructed from overlapping isolates ( Figure  1a) , encoding a 1416-residue polypeptide. Sequence alignments between the murine (mBLM) and human (hBLM) proteins revealed an overall identity of 78% (85% similarity), with highest conservation within their C-terminal halves (90% identity, between residues 657 and 1416) and lower conservation of their N-terminal portions (63% identity, between residues 1 and 656). This high degree of sequence conservation suggested not only that the mBLM coding sequence was complete, but also that there must be a strong functional conservation between the two proteins.
Within their N-terminal halves, the two proteins diered mainly by the length of two short repetitive acidic elements: stretches of nine to ten glutamate and seven to eight aspartate residues (corresponding to GAG or GAT codon repeat, respectively) were found in the mBLM sequence, at positions where only two consecutive glutamate and ®ve consecutive aspartate residues were found in the human homologue (see Figure 1b and d). While these elements were slightly polymorphic in size in the mBLM protein (see legend to Figure 1 ), no such variations had been reported in hBLM. The functional relevance of these repeats and of their variability is presently unknown.
Conservation of the putative BLM helicase domains and elements further C-terminal
Conservation between the human and murine BLM sequences was particularly strong (95% identity) within a region (mBLM residues 657 ± 1090; see Figure 1b and c) spanning the seven helicase domains previously de®ned (Gorbalenya et al., 1989) . A search through protein databases revealed striking homologies between both BLM proteins and RecQ-related DNA helicases, all of which contain a DEAH box (Linder et al., 1989) (located in helicase domain II). Our analysis revealed that a weaker but signi®cant homology extended beyond the seven helicase domains into a region previously named RecQ Ct (Morozov et al., 1997) (positions 1014 ± 1081 in mBLM or 1006 ± 1073 in hBLM). Although less conserved, this region appeared essential since two point-mutations altering highly conserved cysteine residues within the corresponding hBLM region (positions 1036 and 1055) had been found in BS patients (Ellis et al., 1995a; Foucault et al., 1997) . Interestingly, careful sequence comparisons within the RecQ Ct domain revealed a sub-class of proteins comprising all the eukaryotic helicase homologues (except the human and murine WRN proteins). These proteins share a number of additional residues within the RecQ Ct domain (asterisks in Figure 1c ), as well as sequences further C-terminal (not shown). It is tempting to speculate that the members of this subclass of RecQ-like proteins have diverged from their prokaryotic and WRN counterparts by having evolved a new speci®city domain. That this domain serves important functions within the proteins of this subclass is actually supported by the fact that alteration of conserved cysteine residues (positions 1036 and 1055 in hBLM) has been linked to BS (Ellis et al., 1995a; Foucault et al., 1997) . The possibility that these residues, together with other neighbouring cysteine residues (positions 1030 and 1063 in hBLM), are part of a metal-binding element remains to be explored.
The mBLM protein has a 3' to 5' DNA helicase activity From these homologies, it was likely that mBLM had an helicase activity. To directly address this possibility, we tested the activity of puri®ed mBLM in a DNAhelicase assay. The complete mBLM or the truncated mBLMD coding sequences ( Figure 1a ) were expressed as GST-fusions in eukaryotic cells. The full-length mBLM protein was poorly synthesized, suggesting that over-expression of this protein might be toxic for the cell. Nevertheless, after cell extract preparation, the chimeric products were recovered by adsorption onto GSH-agarose beads and introduced into an in vitro helicase assay, using an arti®cial DNA substrate screening this mouse cDNA library with the mBLMD probe resulted in the isolation of several overlapping cDNAs. Together, the two longest (mBLM-1 and mBLM-2) encompass nucleotides 1 ± 4133 (with the ATG initiation codon at position 60). PCR ampli®cation was used to isolate the 3'-terminal portion of the cDNA (mBLM ± PCR), comprising the translation termination codon (TAA, position 4338) and the 3' untranslated region with the poly A signal. The full-length mBLM ORF was reconstructed by in vitro recombination of these partial cDNA clones. (b) Aminoacid alignment of the mouse (mBLM, accession #Z98263) and human (hBLM) BLM proteins. The results of a pairwise comparison between these sequences are reported with vertical dashes between identical residues and double or single dots denoting highly or moderately similar residues. Polymorphic stretches of acidic residues are bracketed. A putative bipartite NLS signal, conserved in hBLM is located between positions 1333 and 1348 (underlined). (c) Aminoacid alignment of the putative helicase domains and immediate surroundings of the mBLM (mmblm residues 671 ± 1081) and hBLM (hsblm) proteins, their Saccharomyces cerevisiae (scsgs1) and Schizosaccharomyces pombe (sprqh1) homologues, the Bacillus subtilis RecQ (bsrecq), the Synechocystis sp. RecQ (ssrecq), the Haemophilus in¯uenzae RecQ (hirecq) the Escherichia coli RecQ (ecrecq), the human RecQ homologue (hsrecq), the Arabidopsis thaliana putative RecQ (atrecq), the Caenorhabditis elegans RecQ (cerecq), the Werner's syndrome protein (hswrn) and its murine homologue (mmwrn). Numbers at the end of each line refer to the position of the corresponding aminoacid in each polypeptide. Dots correspond to gaps inserted by the program to optimize alignments. Identical or related aminoacid residues are highlighted by dark or light shading, respectively. The newly described Cterminal domain and the seven conventional conserved helicase domains (Gorbalenya et al., 1989; Gietz et al,. 1992 ) are overlined. Arrowheads denote positions at which missense mutations were found on BS patients (positions 672, 841, 1036 and 1055, in hBLM) (Ellis et al., 1995a; Foucault et al., 1997) . The lysine residue pointed in helicase domain I (position 703 in mBLM) corresponds to a putative ATP-binding site (Fraser et al., 1997) . Asterisks indicate residues which are conserved only in the subgroup of eukaryotic RecQ-like proteins (see text). (d) Schematic representation of the mBLM protein, with major features and corresponding aminoacid positions indicated. Poly-E and poly-D refer to poly-glutamate and poly-aspartate stretches, a tract of nine (seven independent mBLM cDNA clones) or ten (one clone) glutamate residues at position 221 and a tract of eight (six independent mBLM cDNA clones) or seven (one clone) aspartate residues at position 567. The positions of a putative ATP-binding site (Fraser et al., 1997) and bipartite NLS (Kaneko et al., 1997) are given. RecQ Ct and HRDC (Helicase and RNase D C-terminal) domain limits were named according to (Morozov et al., 1997) ( Figure 2a) . As shown in Figure  2b , the GST-mBLM product catalyzed the displacement of the 24-nt (but not the 27-nt) fragment from the DNA substrate (lanes 5 and 6), whereas under the same conditions, similar amounts (see Figure 2c ) of the unfused GST or the truncated GST-mBLMD ( Figure  2b , lanes 1 ± 4) proteins had no eect. We veri®ed that, under these conditions, a puri®ed TFIIH fraction exhibited both the 3'±5' and 5'±3' helicase activities (signals at both 24 and 27 nt, lane 7), as expected from the function of its XPD/ERCC2 and XPB/ERCC3 subunits, respectively (Schaeer et al., 1993 . Taken together, these results demonstrate that mBLM possesses a speci®c 3'±5' DNA helicase activity and that the putative helicase domain, absent in mBLMD, is essential for this activity.
Examination of the nucleotide requirement of the helicase activity indicated that the reaction was ATPdependent ( Figure 2d , lanes 1 ± 3) and that ATP was exchangeable with dATP (lanes 4 ± 6), but not with dGTP (lane 7) or any other nucleotide (not shown). Since helicases couple the energy of ATP hydrolysis to strand separation of duplex DNA, the requirement for this activity was tested. Substitutions of the invariant lysine within the Walker A-type nucleotide binding box have previously been shown to abolish helicase and ATPase activities in a number of helicases (Walker et al., 1982; Ford et al., 1988; Linder et al., 1989) . Thus a GST-mBLM fusion protein bearing a point mutation in helicase domain I (Fraser et al., 1997) was generated by mutating the invariant lysine residue at position 703 to alanine. The wild-type (wt) and modi®ed (K703A) GST-mBLM cDNA constructs were transfected into COS-7 cells. The chimeric products, which accumulated to similar levels in the transfected cell extracts (Figure 3b ), were assayed for helicase and ATPase activity (Figure 3a and c) . Compared to the wt GSTmBLM, the K703A mutant protein had dramatically reduced helicase and ATPase activities, similar to the truncated mBLMD protein. These experiments clearly demonstrate that mBLM helicase activity requires an intact ATP-binding site. Both ATPase and helicase activities were not signi®cantly altered in the presence of various amounts (6 ± 150 ng per assay) of single or double-stranded DNA.
Mutations leading to the Bloom's syndrome inactivate the BLM helicase activity
The possibility that the genomic instability and related disease symptoms of BS were due to loss of functions other than the helicase activity, remained open since several mutations in patients with BS or the related Werner's syndrome (WS) were located outside of the helicase domains (Ellis et al., 1995a; Yu et al., 1996) . Assuming that, in the cell, BLM establishes essential interactions with other proteins, these alterations may indeed result in loss of functions other than impairment of ATPase and helicase activities (Lu et al., 1996) . On the other hand, three single point-mutations in the BLM gene of patients with BS were identi®ed (Ellis et al., 1995a ) that resulted in aminoacid substitutions at residues conserved in RecQ helicases (Q672P, I841T) or within the above-mentioned subclass of proteins (C1055S) (numbers refer to positions in hBLM, where the ®rst letter represents the aminoacid of the wild-type protein and the last one identi®es the substituting residue).
To determine whether these hBLM point-mutations altered the helicase activity of the BLM protein, the Figure 2 The mBLM protein has 3'±5' DNA helicase activity. (a) The helicase bidirectional DNA substrate used in this study is depicted: single-stranded M13 DNA was annealed with a synthetic 37-nucleotide (nt) DNA segment complementary to the region surrounding the unique EcoRI site; after digestion of the resulting duplex with EcoRI, the linearised molecule was 3'-end labelled (asterisks) in the presence of DNA polymerase I Klenow fragment, [a 32 P]ATP and limiting amount of unlabelled dNTPs, giving rise after limited nucleotide extension to two labelled fragments of 24 and 27 nucleotides . (b) The pGST, pGST-mBLMD and pGST-mBLM vectors (2, 15 and 28 mg, respectively to ensure equal expression levels) were transfected separately into COS-7 cells. Cellular extracts were prepared and 150 (lanes 1, 3 and 5) or 400 mg (lanes 2, 4 and 6) were incubated with GSH-agarose beads. After washing, the GSH-complexed proteins were assayed for DNA helicase activity (lanes 1 ± 6). A puri®ed TFIIH fraction (Schaeer et al., 1993) , with bidirectional helicase activity, was used as control (lane 7). Non-reacted DNA substrate, either native (lane 9) or heat-denatured (lane 8), was run in parallel. Directions of helicase translocation on the M13 DNA substrate are indicated on the left, with the positions of the corresponding displaced oligonucleotides pointed on the right. (c) The GSH-bound proteins used for the helicase assays were separated by SDS ± PAGE, transferred to nitrocellulose and reacted with anti-GST monoclonal antibodies. Speci®c immune-complexes were visualized with the ECL detection system (arrow-heads). The higher band in lane 1 is non speci®c. Molecular sizes (kDa) are given on the right. (d) Equal amounts of GST-mBLM fusion protein, puri®ed by GSH-adsorption as described above, were assayed for helicase activity (lanes 1 ± 7) in the presence of increasing concentrations (0.04, 0.4 and 4 mM) of ATP (lanes 1 ± 3), dATP (lanes 4 ± 6), or 4 mM dGTP (lane 7). Native (lane 8) or heatdenatured (lane 9) DNA substrate was run in parallel. Direction of helicase translocation and position of displaced oligonucleotides are indicated. In this particular experiment, the 27-nt oligonucleotide was poorly labelled compared to the 24-nt oligonucleotide, but could be easily visualized after longer exposure (not shown) same mutations were introduced at equivalent positions into the mBLM cDNA, so as to generate the Q680P, I849T and C1063S derivatives of mBLM. The resulting constructs were transfected and assayed for helicase and ATPase activities (Figure 3a and c) . Like the truncated GST-mBLMD, none of these mutant mBLM chimeras displayed signi®cant levels of these enzymatic activities, strongly suggesting that impairment of the helicase and associated ATPase activities is the primary cause of BS establishment. Not only do these results con®rm the prediction that most BS mutations result in loss of function of BLM, but also do they agree with the autosomal recessive transmission of BS (Ellis et al, 1995a) .
Discussion
We have isolated a murine cDNA that encodes a polypeptide (mBLM) which is highly related to the protein involved in the human Bloom's syndrome (BS) and exhibits ATP-dependent DNA-helicase activity. BS is characterized by mutations within the BLM gene whose original eects are excessive chromosome breakage and increased rates of sister chromatide interchange in somatic cells (German, 1993) . We show that single aminoacid substitutions found in BS cells, within the helicase region of the otherwise intact BLM, when introduced into the highly homologous mBLM protein, abolished both ATPase and DNA-helicase activities of this protein. These results clearly suggest that impairment of these enzymatic activities is the primary cause of BS setting up. Moreover, the isolation of the corresponding mouse sequences will allow the establishment of an animal model of BS which is presently lacking. Our observation that human BS mutations abolish the enzymatic activities of the murine protein further supports this possibility.
Sequence comparisons between all known helicases showed, as expected, high conservation within the helicase domains. Furthermore, this analysis revealed that the BLM proteins belong to a sub-class of RecQlike helicases sharing critical residues within a region (RecQ Ct) located C-terminal to the helicase domains. Intriguingly, within the N-terminal half of the protein, mBLM exhibits two short repeats of acidic residues (glutamate and aspartate residues, respectively; Figure  1b and d) which appear slightly polymorphic in length. These repetitions are located at positions that align with identical, albeit less repeated residues in hBLM. A number of genetic diseases have been shown to be caused by unstable expansions of trinucleotide repeats (see for recent reviews Mandel, 1997; Richards and Sutherland, 1997) . Although the stretches described here are encoded by pure repeats of trinucleotides (GAG and GAT repeats, respectively), no BS mutations has so far been correlated with similar expansions.
Werner's syndrome (WS) is another genetic disease linked to mutations within a gene encoding a protein (WRN) with DNA-helicase activity (Suzuki et al., 1997; Gray et al., 1997) . WRN mutants have been characterized that retained the helicase domains but had lost their nuclear localization signal (NLS) and stayed within the cytoplasm . A putative NLS could also be identi®ed in the BLM sequences (see Figure 1b ) and the protein eciently accumulated within the cell nucleus upon over-expression (Kaneko et al., 1997; FDG, unpublished) . Interestingly, while all of the mBLM point-mutants tested in this study retained an intact NLS, all of them, except K703A, showed signi®cantly reduced nuclear targeting (AB, FDG, CK and BC in preparation). It is possible therefore that these particular mutations somehow interfere with proper nuclear transport. If, on top of its ATPase and DNA-helicase activities, the BLM protein serves additional functions within the nucleus, impairment of nuclear transport would also aect these yet unknown properties. Careful comparisons of the detailed perturbations of cells from BS patients with normal and altered BLM subcellular distributions should help identify these additional putative functions. (28 mg) and the truncated variant GST-mBLMD (15 mg) were transfected separately in COS-7 cells. Cellular extracts were prepared and 100 (lanes 1, 3, 5, 7, 9 and 11) or 400 mg (lanes 2, 4, 6, 8 and 10) of corresponding proteins were adsorbed on GSH-agarose beads. After extensive washing, the GSH-trapped proteins were assayed for DNA helicase activity. Control lanes (12 ± 13) were as in Figure 2a (lanes 8  and 9) . Directions of the helicase translocation on the M13 substrate DNA and positions of displaced oligonucleotides are indicated. (b) The GSH-beads used for the helicase assays were then boiled in sample buer and submitted to Western-blot (WB) analysis (as described in Figure 2 ). Bands corresponding to the GST-mBLM derivatives are pointed. The bands with higher mobilities correspond to partial degradation products of the GST-BLM derivatives. (c) Proteins corresponding to 50 mg of the extract were trapped on GSH-agarose, eluted with 30 ml of 5 mM glutathione and 3 ml of the eluate were assayed for ATPase activity. The hydrolysis products of the [g 32 P]ATP substrate were separated by poly-ethyleneimine chromatography: released phosphate (Pi) was visualized by autoradiography and relative amounts of free phosphate are indicated. Assays without protein (lane 7) or in the presence of a semi-puri®ed TFIIH fraction (lane 8) were run in parallel as controls Although WRN and BLM share sequence and biochemical similarities (Ellis, 1997; and our results) , their physiological functions appear dierent when comparing their expression pattern and the clinical symptoms that arise from corresponding gene defects. Expression of WRN is rather organ-speci®c: elevated in heart, placenta, muscle, pancreas, and low in lung, brain, kidney (Yu et al., 1996) . On the other hand, mBLM synthesis seems to be more ubiquitous, although it accumulates to larger extents in some organs (brain, thymus, salivary glands, intestine, testis) or epithelia, as revealed by in situ hybridization studies (FDG, unpublished data) . Furthermore, while individuals with BS exhibit severe growth retardation through whole life (German, 1993) , patients with WS have normal height until puberty, when they fail to undergo the adolescent growth spurt and exhibit features of premature ageing (Epstein et al., 1966) . Both syndromes have cancer predisposition, but in BS the cancer spectrum resembles that seen in the general population (German, 1993) , whereas in WS non epithelial cancers predominate (Goto et al., 1996) .
Based on the distinct clinical symptoms arising from defects in the human WRN and BLM genes, it appears that the physiological functions of the corresponding proteins must be dierent. This functional divergence is further substantiated by our observation that the WRN protein does not belong to the same sub-class of RecQlike helicases than BLM (see above and Figure 1c) . Identi®cation of the precise functions of the BLM and WRN proteins, awaits further characterization of the properties of the respective RecQ Ct regions and the identi®cation of potential molecular targets of these sequences, within the cell.
The BLM proteins share strong homologies with the yeast Sgs1 protein. This helicase, which was ®rst identi®ed by a mutation that suppressed the slow growth phenotype of mutations in the type I topoisomerase Top3 gene (Ganglo et al., 1994) , was subsequently shown to interact also with the type II topoisomerase Top2 (Watt et al., 1995) . These interactions have been postulated to be instrumental in Sgs1-mediated chromosome segregation (Watt et al., 1995) . It will be of prime interest to examine whether, like Sgs1, the BLM proteins interact with homologous mammalian topoisomerases.
More recently, mutation of Sgs1 was shown to cause premature ageing in yeast, as re¯ected by a shortened life-span of mother cells and nucleolar swelling and fragmentation (Sinclair et al., 1997) . In keeping with these ®ndings, our observation (not shown) that overexpression of mBLM leads to perinucleolar accumulation of the protein may be relevant and deserves further investigation.
Finally, the interaction of mBLM with the ATFa transcription factors, as revealed by the two-hybrid assay (AB, FDG, CK and BC, in preparation), is intriguing. This observation suggests that BLM may be recruited to speci®c promoters by ATFa. Alternatively, the ATFa proteins may be directed through these interactions to particular DNA sites requiring BLM intervention. These interesting possibilities are now open to investigation and should provide some clues as to the respective contributions of ATFa and BLM in both transcription and recombination processes.
Materials and methods
Reconstruction of the full-length mBLM cDNA
A partial mBLM cDNA (mBLMD) was initially isolated by two-hybrid screening of a 10-day mouse embryo VP16-fusion cDNA library (gift from J-M Garnier), using ATFa1 (residues 1 ± 293) as a bait (AB, FDG, CK and BC, in preparation). To complete this partial cDNA, the original library was re-screened by hybridization with the corresponding random-primed 32 P-labelled cDNA fragments (Ausubuel et al., 1987) . Fifteen independent overlapping cDNAs were isolated and sequenced. The 3'-end was isolated by two successive rounds of PCR ampli®cation, using poly-dT and oligonucleotides corresponding to the 3'-terminal region of the mBLM2 insert as primers. To reconstitute the full-length cDNA, the PCRgenerated SpeI ± NotI fragment, which was entirely sequenced, has ®rst been inserted into the SK-mBLM2 plasmid that was released from the recombinant phage (Stratagene) bearing the mBLM2 sequence. A S®I ± NotI fragment from the resulting construct was then cloned in the SK-mBLM1 plasmid, generating the SK-mBLM plasmid.
Eukaryotic expression vectors
Glutathione-S-transferase (GST)-fusion proteins were expressed from recombinant pBC vectors (Chatton et al., 1995) . The pGST-mBLMD and pGST-mBLM vectors were generated by cloning of the mBLMD and SK-mBLM inserts into the pBC polylinker, in-frame with the GST coding sequence. Mutations of residues Q680, K703, I849 and C1063 of the mBLM protein were constructed by oligonucleotide-directed mutagenesis (Kunkel et al., 1987) of pGST-mBLM.
Transfections, extracts and GST pull-down assays COS-7 cells, grown as monolayers, were transfected by calcium-phosphate coprecipitation, 2 h after plating, with recombinant plasmids (adjusted to 28 mg per 14 cm Petri dish, with pBluescript as carrier DNA), as previously described (Chen and Okayama, 1987) . The medium was changed 20 h later. The day after, the cells were harvested in phosphate-buered saline (PBS) and resuspended in 300 ml of lysis buer (0.4 M KCl, 20 mM Tris-HCl, pH 7.5, 20% glycerol, 5 mM dithiothreitol, 0.4 mM PMSF, 2.5 ng each of leupeptin, pepstatin, aprotinin, antipain and chymostatin per ml). After three freeze-thawing steps in liquid nitrogen, the resulting cell lysate was cleared by centrifugation for 20 min at 10 000 g (Kumar and Chambon, 1988). After an additional clearing step on protein A-Sepharose, aliquots of about 400 mg protein were incubated (3 h at 48C) with 30 ml of a 10% suspension of glutathione (GSH)-agarose beads in PBS containing 0.5% NP-40. The GSH-beads were washed three times with 1 ml of the same buer and the adsorbed proteins were submitted to the helicase or ATPase assays. The proteins were then dissociated by boiling for 5 min in 20 ml sample buer, before SDS-10% polyacrylamide gel electrophoresis (SDS ± PAGE).
Enzymatic assays
Helicase activity was assayed as previously described (Schaeer et al., 1993 . Brie¯y, GSH-beads were incubated for 45 min at 378C in the presence of 20 mM Tris-HCl, pH 7.8, 4 mM MgCl 2 , 0.04, 0.4 or 4 mM ATP, 250 mg/ml insulin (as an enzyme protector), 1 mM dithiothreitol and 1 ± 3 ng of 32 P-labelled DNA substrate (see Figure 3a ). Reactions were stopped by addition of 20 mM EDTA and 0.2% SDS, and analysed by 10% PAGE, under non-denaturing conditions. After electrophoresis, the gel was dried, ®xed in a mixture of 10% ethanol and 10% acetic acid and submitted to autoradiography.
Enzymatic hydrolysis of ATP was assessed as previously described (in the presence of 45 ng of plasmidic DNA per assay) on protein fractions eluted with 5 mM glutathione from GSH-agarose beads, to reduce background ATPase activity.
Antibodies and immunoblots
Monoclonal antibodies against GST were a gift from Y Lutz. Speci®c protein analysis by Western-blotting was carried out as previously described (Bocco et al., 1996) .
